Security key
29384C108
Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)
CUSIP: 29384C108
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 105,721
- Total 13F value
- $772,493
- Share change
- +72,043
- SEC-reported price per share
- $7.36
- Number of holders
- 20
- Value change
- +$523,528
- Number of buys
- 14
- Number of sells
- 3
- Shares outstanding
- 38,346,880
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
20
Top holders
10
TRDA full security history
Ownership snapshot
Full 13F holder table
Entrada Therapeutics, Inc. SEC filings
Entrada Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29384C108
Recent filing periods:
Ownership snapshot
Top reported holders of TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
5AM Ventures V, L.P.
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
3/4/5
13D/G
13F
Lead comparable stake: 11%
13D/G row: 5AM Ventures V, L.P.
Showing 1-6 of 15 holder rows.
Quick read
5AM Ventures V, L.P. leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 5AM Ventures V, L.P.'s linked filing trail.
Comparable ownership
Top 5
5AM Ventures V, L.P.
11%
ROCHE FINANCE LTD
6.9%
BlackRock, Inc.
5.3%
TCG Crossover GP I, LLC
5%
Janus Henderson Group Ltd.
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 5AM Ventures V, L.P. |
3/4/5
13D/G
10%+ Owner · Kush Parmar
|
11%
from 13D/G
|
$32,831,654
4,056,379 shares
|
-$1,760,000 | 14 Nov 2025 |
| ROCHE FINANCE LTD |
13D/G
|
6.9%
|
$23,019,270
2,569,115 shares
|
$0 | 31 Dec 2024 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.3%
from 13D/G
|
$29,767,968
2,358,793 shares
|
— | 31 Mar 2026 |
| TCG Crossover GP I, LLC |
13D/G
|
5%
|
$11,849,186
1,917,344 shares
|
$0 | 19 Nov 2025 |
| Janus Henderson Group Ltd. |
13D/G
JANUS HENDERSON GROUP PLC
|
4%
|
$9,964,391
1,521,281 shares
|
-$3,932,443 | 30 Jun 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
13D/G
Company · T. Rowe Price Associates, Inc.
|
0.9%
from 13D/G
|
$6,639,000
526,043 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
20
Shares
105,721
Rows available
20
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
118
Q2 2026 holders
20
Holder diff
-98
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend